EP4701639A1 - Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davon - Google Patents
Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davonInfo
- Publication number
- EP4701639A1 EP4701639A1 EP24735441.8A EP24735441A EP4701639A1 EP 4701639 A1 EP4701639 A1 EP 4701639A1 EP 24735441 A EP24735441 A EP 24735441A EP 4701639 A1 EP4701639 A1 EP 4701639A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- forms
- peptide
- infected tissue
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363470002P | 2023-05-31 | 2023-05-31 | |
| PCT/US2024/031548 WO2024249553A1 (en) | 2023-05-31 | 2024-05-30 | Molecules targeting infected tissues and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4701639A1 true EP4701639A1 (de) | 2026-03-04 |
Family
ID=91620594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24735441.8A Pending EP4701639A1 (de) | 2023-05-31 | 2024-05-30 | Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davon |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4701639A1 (de) |
| WO (1) | WO2024249553A1 (de) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| EP1817003B1 (de) | 2004-10-29 | 2018-02-21 | The Regents of The University of California | Poröse silicium-micropartikeln zur verabreichung von wirkstoffen ins auge |
| CN101815504B (zh) | 2007-07-10 | 2013-11-20 | 加利福尼亚大学董事会 | 用于向所选择组织递送组合物的材料和方法 |
| US8404636B2 (en) * | 2008-07-17 | 2013-03-26 | George Mason Intellectual Properties, Inc. | Targeted delivery of antimicrobial agents |
| WO2016172515A1 (en) * | 2015-04-23 | 2016-10-27 | Sanford Burnham Prebys Medical Discovery Institute | Targeted delivery system and methods of use therefor |
| CN114533898B (zh) | 2015-07-09 | 2025-07-01 | 加利福尼亚大学董事会 | 融合脂质体包被的多孔硅纳米颗粒 |
| WO2018085846A1 (en) * | 2016-11-07 | 2018-05-11 | The Regents Of The University Of California | Multifunctional antibiotic-peptide conjugates: synthesis and antimicrobial activities |
| US20210000744A1 (en) | 2018-03-27 | 2021-01-07 | The Regents Of The University Of California | Drug delivery formulations |
| WO2020161602A1 (en) * | 2019-02-04 | 2020-08-13 | University Of Tartu | Bi-specific extracellular matrix binding peptides and methods of use thereof |
-
2024
- 2024-05-30 EP EP24735441.8A patent/EP4701639A1/de active Pending
- 2024-05-30 WO PCT/US2024/031548 patent/WO2024249553A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024249553A1 (en) | 2024-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240042063A1 (en) | LINKED AND OTHER pH-TRIGGERED COMPOUNDS | |
| US20210052507A1 (en) | Drugs and gene carrier particles that rapidly move through mucous barriers | |
| CA2722183C (en) | Nanostructures suitable for sequestering cholesterol and other molecules | |
| US11554097B2 (en) | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents | |
| JP2008540544A (ja) | Ｒｎａｉｉｉ阻害ペプチドを投与するための組成物 | |
| JP2017502931A5 (de) | ||
| Papadia et al. | Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept | |
| BR112016030172B1 (pt) | Aptâmeros específicos para tlr-4 e usos dos mesmos | |
| WO2012112767A2 (en) | Collagen-targeted nanoparticles | |
| AU2020218940B2 (en) | Bi-specific extracellular matrix binding peptides and methods of use thereof | |
| US11952431B2 (en) | Neutrophil-binding peptides | |
| ES2872552T3 (es) | Nanopartículas poliméricas y métodos de preparación y de uso de las mismas | |
| EP4701639A1 (de) | Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davon | |
| WO2014059385A1 (en) | Methods and small molecule therapeutics comprising fused elps | |
| WO2017210693A1 (en) | Protein polymer fusions for subcutaneous delivery of small molecules | |
| JP2022501423A (ja) | 医薬ベシクル製剤を調製するための方法、ならびに関連する製品および使用 | |
| WO2012118778A1 (en) | Truncated car peptides and methods and compositions using truncated car peptides | |
| US20200268832A1 (en) | Compositions for delivery to and treatment of atherosclerotic plaques | |
| JP5250229B2 (ja) | カーボンナノホーン | |
| JP2018534317A (ja) | 結腸がんの処置および検出のための組成物および方法 | |
| Rani et al. | Engineered Bacterial Membrane Vesicles for Advanced Biomedical Applications | |
| Pérez-Guillén et al. | Studying Lipid Membrane Interactions of a Super-Cationic Peptide in Model Membranes and Living Bacteria. Pharmaceutics 2022, 14, 2191 | |
| HK40090445A (zh) | 靶组织特异性递送型药物递送系统用胶囊的用途 | |
| WO2021155198A1 (en) | Nanomaterials for targeted treatment and imaging of aneurysmal microenvironment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251124 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |